KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Shares Issued (2018 - 2025)

Historic Shares Issued for Aquestive Therapeutics (AQST) over the last 8 years, with Q3 2025 value amounting to $296000.0.

  • Aquestive Therapeutics' Shares Issued rose 5336.79% to $296000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $346000.0, marking a year-over-year decrease of 5324.32%. This contributed to the annual value of $732000.0 for FY2024, which is 177692.31% up from last year.
  • Aquestive Therapeutics' Shares Issued amounted to $296000.0 in Q3 2025, which was up 5336.79% from $50000.0 recorded in Q2 2025.
  • In the past 5 years, Aquestive Therapeutics' Shares Issued ranged from a high of $9.9 million in Q1 2021 and a low of -$24.4 million during Q4 2021
  • For the 5-year period, Aquestive Therapeutics' Shares Issued averaged around $95428.6, with its median value being $417500.0 (2024).
  • Within the past 5 years, the most significant YoY rise in Aquestive Therapeutics' Shares Issued was 1379354.84% (2021), while the steepest drop was 49666.83% (2021).
  • Quarter analysis of 5 years shows Aquestive Therapeutics' Shares Issued stood at -$24.4 million in 2021, then surged by 84.55% to -$3.8 million in 2022, then surged by 100.21% to $8000.0 in 2023, then soared by 2312.5% to $193000.0 in 2024, then surged by 53.37% to $296000.0 in 2025.
  • Its Shares Issued stands at $296000.0 for Q3 2025, versus $50000.0 for Q2 2025 and $193000.0 for Q3 2024.